Sung E. Choe

10.8k citations
57 papers · 8.5k · 8 hit papers · h-index 32

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
  • Genetics top 0.5%
    • Glioma Diagnosis and Treatment

Papers in

Sung E. Choe

55 papers receiving 8.4k citations

Sung E. Choe's Hit Papers

Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial 2023 · 157 citations
1570+5+10Years since publication50010001.5k2.0k

Peers

Sung E. Choe
Comparison fields: 5 of 97
  • Hematology 2.5k
  • Genetics 924
  • Cancer Research 679
  • Molecular Biology 1.2k
  • Surgery 607
Replace Fenghuang Zhan with:
Fenghuang Zhan United States
Hitoshi Ichikawa Japan
Yupo Ma United States
Miguel Angel Villalona-Calero United States
David C. Boulware United States
P. Nagesh Rao United States
Karin Vanderkerken Belgium
Wei Xu China
Wenming Xiao United States
Colette Adida France
Sung E. Choe relative to Fenghuang Zhan United States Fenghuang Zhan's profile →
Citations per field
00.5×2×4×6×7.8×
Fenghuang Zhan · 1×
Citations per year

Countries citing papers authored by Sung E. Choe

Since Specialization
Citations

This map shows the geographic impact of Sung E. Choe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sung E. Choe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sung E. Choe more than expected).

Fields of papers citing papers by Sung E. Choe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sung E. Choe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sung E. Choe. The network helps show where Sung E. Choe may publish in the future.

Co-authors

The 25 scholars most cited alongside Sung E. Choe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sung E. Choe Line = papers co-authored together Sung E. Choe links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Hit paper breakdown →
20102301
2
Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML
Hit paper breakdown →
20181182
3
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations
Hit paper breakdown →
2017400
4
Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 Mutation
Hit paper breakdown →
2021384
5 2016370
6
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Hit paper breakdown →
2019311
7 2005300
8
Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
Hit paper breakdown →
2020250
9 2018235
10
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Hit paper breakdown →
2021206
11 2020188
12 2018181
13 2019178
14 2020170
15
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
Hit paper breakdown →
2023157
16 2012155
17 2020145
18 2020128
19 2011126
20 2013119

About Sung E. Choe

Sung E. Choe is a scholar working on Hematology, Cancer Research, Genetics, Oncology and Surgery, having authored 57 papers that have together received 8.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (22 papers), Glioma Diagnosis and Treatment (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Treatments and Mutations (1 paper), Bone Tumor Diagnosis and Treatments (1 paper) and Cancer Cells and Metastasis (1 paper). The work is most often cited by research in Hematology (2.5k citations), Genetics (924 citations), Cancer Research (679 citations), Molecular Biology (1.2k citations) and Surgery (607 citations). Sung E. Choe has collaborated with scholars based in United States, France and Germany. Frequent co-authors include George McDonald Church, Alan M. Michelson, Marc S. Halfon, Michael Boutros, Marion Dorsch, Stefan Größ, Joshua C. Murtie, Michelle F. Clasquin, Scott A. Biller and Everton Mandley. Their work appears in journals such as Blood, Cancer Discovery, Molecular BioSystems, PLoS ONE and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact